Get started
Author

Marta Iruarrizaga‐Lejarreta

Observed names: M. Iruarrizaga-Lejarreta, M. Iruarrizaga‐Lejarreta, Marta Iruarrizaga, Marta Iruarrizaga Lejarreta, Marta Iruarrizaga-Lejarreta
Institution: OWL (Spain)
ORCID: 0000-0002-3836-0162
Observed ORCID: 0000-0002-3836-0162
OpenAlex ID: A5086632104
Schwann cell autophagy, myelinophagy, initiates myelin clearance from injured nerves
2015 · Jose A. Gomez-Sanchez, Lucy Carty, et al. · The Journal of Cell Biology · 465
Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis
2017 · Cristina Alonso, David Fernández-Ramos, et al. · Gastroenterology · 269
Role of aramchol in steatohepatitis and fibrosis in mice
2017 · Marta Iruarrizaga‐Lejarreta, Marta Varela‐Rey, et al. · Hepatology Communications · 115
PDF
Integrative Analysis of Fecal Metagenomics and Metabolomics in Colorectal Cancer
2020 · Marc Clos-Garcia, Koldo Garcia, et al. · Cancers · 99
PDF
Human antigen R contributes to hepatic stellate cell activation and liver fibrosis
2012 · Ashwin Woodhoo, Marta Iruarrizaga-Lejarreta, et al. · Hepatology · 88
PDF
S-adenosylmethionine Levels Regulate the Schwann Cell DNA Methylome
2014 · Marta Varela-Rey, Marta Iruarrizaga-Lejarreta, et al. · Neuron · 78
PDF
Pilot Multi-Omic Analysis of Human Bile from Benign and Malignant Biliary Strictures: A Machine-Learning Approach
2020 · Jesús M. Urman, José M. Herranz, et al. · Cancers · 71
PDF
Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profiles
2022 · Ibon Martínez‐Arranz, Chiara Bruzzone, et al. · Hepatology · 70
PDF
The L‐α‐Lysophosphatidylinositol/G Protein–Coupled Receptor 55 System Induces the Development of Nonalcoholic Steatosis and Steatohepatitis
2020 · Marcos F. Fondevila, Uxia Fernandez, et al. · Hepatology · 65
PDF
Alteration in the Cerebrospinal Fluid Lipidome in Parkinson’s Disease: A Post-Mortem Pilot Study
2021 · Joaquín Fernández-Irigoyen, Paz Cartas-Cejudo, et al. · Biomedicines · 64
PDF
Obeticholic Acid Modulates Serum Metabolites and Gene Signatures Characteristic of Human NASH and Attenuates Inflammation and Fibrosis Progression in Ldlr‐/‐.Leiden Mice
2018 · Martine C. Morrison, Lars Verschuren, et al. · Hepatology Communications · 61
PDF
HuR/ELAVL1 drives malignant peripheral nerve sheath tumor growth and metastasis
2020 · Marta Palomo-Irigoyen, Encarni Pérez-Andrés, et al. · Journal of Clinical Investigation · 57
PDF
A structurally engineered fatty acid, icosabutate, suppresses liver inflammation and fibrosis in NASH
2021 · David A. Fraser, Xiaoyu Wang, et al. · Journal of Hepatology · 43
Randomised clinical trial: a leucine‐metformin‐sildenafil combination ( NS ‐0200) vs placebo in patients with non‐alcoholic fatty liver disease
2018 · N. Chalasani, R. Vuppalanchi, et al. · Alimentary Pharmacology & Therapeutics · 41
PDF
Arachidyl amido cholanoic acid improves liver glucose and lipid homeostasis in nonalcoholic steatohepatitis via AMPK and mTOR regulation
2020 · David Fernández-Ramos, Fernando Lopitz-Otsoa, et al. · World Journal of Gastroenterology · 39
PDF
Endogenous cortisol excess confers a unique lipid signature and metabolic network
2021 · Arturo Vega-Beyhart, Marta Iruarrizaga, et al. · Journal of Molecular Medicine · 31
The lipidome of endometrial fluid differs between implantative and non-implantative IVF cycles
2019 · Roberto Matorras, Ibon Martinez-Arranz, et al. · Journal of Assisted Reproduction and Genetics · 31
PDF
Interplay between Genome, Metabolome and Microbiome in Colorectal Cancer
2021 · Koldo Garcia-Etxebarria, Marc Clos-Garcia, et al. · Cancers · 28
Icosabutate Exerts Beneficial Effects Upon Insulin Sensitivity, Hepatic Inflammation, Lipotoxicity, and Fibrosis in Mice
2019 · Anita M. van den Hoek, Elsbet J. Pieterman, et al. · Hepatology Communications · 23
Dual targeting of hepatic fibrosis and atherogenesis by icosabutate, an engineered eicosapentaenoic acid derivative
2020 · Geurt Stokman, Anita M. van den Hoek, et al. · Liver International · 17
PDF
The RNA-Binding Protein Human Antigen R Controls Global Changes in Gene Expression during Schwann Cell Development
2012 · Marta Iruarrizaga-Lejarreta, Marta Varela-Rey, et al. · Journal of Neuroscience · 13
PDF
Utility of Metabolomic Biomarkers to Identify Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients
2021 · Christopher J. Mowry, Cristina Alonso, et al. · Transplantation Direct · 10
Lipidomics and biodistribution of extracellular vesicles‐secreted by hepatocytes from Zucker lean and fatty rats
2024 · Maria Azparren‐Angulo, Justyna Mleczko, et al. · Journal of Extracellular Biology · 6
PDF
Emerging Circulating Biomarkers for The Diagnosis and Assessment of Treatment Responses in Patients with Hepatic Fat Accumulation, Nash and Liver Fibrosis
2019 · Marta Iruarrizaga-Lejarreta, Fernando Bril, et al. · Springer eBooks · 6
Targeting the NAFLD metabolome and the shaping of precision medicine for patients with NASH
2018 · M. Iruarrizaga-Lejarreta, I. Martínez-Arranz, et al. · Journal of Hepatology · 3
Works count: 42
Citation count: 1,798
H-index: 19
I10-index: 22
Year
Topic
Type